Investigational Site Number 410002

Seoul 138-736

0 studies enrolling now · 11 studies all time

What they study most

Acute Coronary Syndrome, Cancer, Hematopoietic Neoplasm, Idiopathic Pulmonary Fibrosis, Non-small Cell Lung Cancer, Prostate Cancer, Rheumatoid Arthritis, Small Cell Lung Cancer, Type 2 Diabetes Mellitus, Venous Thromboembolism

Studies at this site

• Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia — Completed
• Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis — Completed
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications — Completed
• Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients — Completed
• Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer — Completed
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed
• Sarilumab Effect on the Pharmacokinetics of Simvastatin — Completed
• Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer — Completed
• Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer — Completed
• Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery — Completed
• Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy — Completed